Filtered By:
Infectious Disease: COVID-19
Vaccination: Vaccines
This page shows you your search results in order of date. This is page number 16.
Order by Relevance | Date
Total 391 results found since Jan 2013.
Mechanistic Episodes on SARS-CoV-2-Mediated Neurological Manifestations and Their Possible Therapeutic Interventions
J Environ Pathol Toxicol Oncol. 2022;41(1):85-98. doi: 10.1615/JEnvironPatholToxicolOncol.2021040128.ABSTRACTRecently, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been critically recognized and spread rapidly on this planet. Considerable recognition of SARS-CoV-2 has been known with a range of viruses that are more capable to cause diseases in avian and mammals including humans. The virus was found as a main culprit for major defects in respiratory system and thereby caused severe acute respiratory syndrome disease. This has led to depict the mortality in human population. Nevertheless...
Source: Journal of Environmental Pathology, Toxicology and Oncology - April 4, 2022 Category: Environmental Health Authors: Sobia Nida Hemalatha Srinivisan Ashok Kumar Pandurangan Mohammad Waseem Source Type: research
Safety of SARS-CoV-2 vaccination in patients with Behcet ’s syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine
AbstractMost of the published data relate to classical forms of rheumatic diseases (RD) and information on rare inflammatory disorders such as Beh çet’s syndrome (BS) and familial Mediterranean fever (FMF) is limited. We studied the frequency of side effects and disease flares after COVID-19 vaccination with either Pfizer/BioNTech or Sinovac/CoronaVac in 256 patients with BS, 247 with FMF, and 601 with RD. Telephone interviews were conducte d using a questionnaire survey in a cross-sectional design in patients with BS, FMF, and RD followed by a single university hospital. Study participants were vaccinated either with C...
Source: Rheumatology International - April 4, 2022 Category: Rheumatology Source Type: research
Clinical characteristics of patients with acute ischemic stroke previously vaccinated against COVID-19
The aim of this study was to examine the clinical characteristics of patients with acute ischemic stroke which were previously vaccinated against Coronavirus Disease 2019 (COVID-19) and determine whether the vaccine had impact on outcome.
Source: Journal of Stroke and Cerebrovascular Diseases - April 3, 2022 Category: Neurology Authors: Marija Stamenkovi ć, Ljiljana Radmilo, Mirjana Jovićević, Tamara Rabi-Žikić, Marija Žarkov, Svetlana Ružička-Kaloci, Svetlana Simić, Aleksandar Stamenković, Željko Živanović Source Type: research
Acute Thalamic Ischemic Stroke in an Older Patient Newly Vaccinated with COVID-19 Vaccine Based on Adenoviral Vectors
by Kelly Mesa-Gamarra, MD; Mario Pineda-Paternina, MD; Edgar Castillo, MD; Loida Camargo, MD, MSc; Alexander Pabón, MD; Jorge Herrera-Pino, MD, PhD; Nicole Caldichoury, MSc; Pascual A. Gargiulo, MD, PhD; Yuliana Flórez, MSc; and Norman López, PhD Drs. Mesa-Gamarra, Pineda-Paternina, and Pabón are physicians, neurology residents with Universidad del Sinú in Cartagena, Colombia. Dr. Castillo is Chief of […]
The post Acute Thalamic Ischemic Stroke in an Older Patient Newly Vaccinated with COVID-19 Vaccine Based on Adenoviral Vectors appeared first on Innovations in Clinical Neuroscience.
Source: Innovations in Clinical Neuroscience - April 1, 2022 Category: Neuroscience Authors: ICNS Online Editor Tags: Case Report Current Issue Neurology Covid-19 Ischemic stoke vaccinated Source Type: research
New Janssen Initiative Aims to Advance Equitable Care and Address Hidden Threat of Amputation Related to Peripheral Artery Disease (PAD)
TITUSVILLE, N.J., March 31, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of Save Legs. Change Lives.™ Spot Peripheral Artery Disease Now, a multi-year initiative aimed at creating urgency and action to address the hidden threat of peripheral artery disease (PAD)-related amputation, with an initial focus on reaching Black Americans, who are more than twice as likely to be impacted by PAD.1 Janssen has joined forces with leading professional associations, healthcare systems and community organizations to advance equitable care for individuals and communities placed at an...
Source: Johnson and Johnson - March 31, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
The hospitalization rate of cerebral venous sinus thrombosis before and during COVID-19 pandemic era: A single-center retrospective cohort study
In this study, we aimed to compare the hospitalization rate of CVST before and during the COVID-19 pandemic (before vaccination program).
Source: Journal of Stroke and Cerebrovascular Diseases - March 24, 2022 Category: Neurology Authors: Maryam Vasaghi Gharamaleki, Maryam Habibagahi, Etrat Hooshmandi, Reza Tabrizi, Shahram Arsang-Jang, Zohreh Barzegar, Nima Fadakar, Vahid Reza Ostovan, Abbas Rahimi-Jaberi, Nahid Ashjazadeh, Peyman Petramfar, Maryam Poursadeghfard, Sadegh Izadi, Masoumeh N Source Type: research
Thrombotic events following Covid-19 vaccines compared to Influenza vaccines
CONCLUSIONS AND RELEVANCE: This study shows a significant increase in thrombotic events in subjects vaccinated with Covid-19 vaccines in comparison to a control group. The clinical implication of these findings should be interpreted with caution, in light of the high effectiveness of vaccination and the inherent risk of thrombosis from Covid-19 infection itself.PMID:35288031 | DOI:10.1016/j.ejim.2022.03.002
Source: European Journal of Internal Medicine - March 15, 2022 Category: Internal Medicine Authors: Marcelo Gabriel Vallone Andre Luis Falc ón Horacio Matias Castro Augusto Ferraris Ramiro Francisco Cantarella Mar ía Inés Staneloni Valeria Ines Aliperti Analia Ferloni Daniela Mezzarobba Fernando Javier V ázquez Mar ía Florencia Grande Ratti Source Type: research
Early-Onset Myasthenia Gravis Following COVID-19 Vaccination
J Korean Med Sci. 2022 Mar 14;37(10):e50. doi: 10.3346/jkms.2022.37.e50.ABSTRACTAs coronavirus disease 2019 (COVID-19) has spread worldwide, the rate of COVID-19 vaccination uptake is encouraging. Neurological complications associated with COVID-19 vaccines such as stroke, Guillain-Barré syndrome, and Bell's palsy have been reported. Recently, late-onset myasthenia gravis (MG) following COVID-19 vaccination has been reported. To date, however, there has been no evidence of increased risk of early-onset MG following COVID-19. Here, we report a case of a patient with new-onset MG that arose after receiving a COVID-19 vaccin...
Source: J Korean Med Sci - March 15, 2022 Category: General Medicine Authors: Myung Ah Lee Chonghwee Lee Jung Hyun Park Jung Hwan Lee Source Type: research
